Patents by Inventor Jonathan Michael Yingling

Jonathan Michael Yingling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Quinolinyl-pyrrolopyrazoles
    Patent number: 7834029
    Abstract: A compound according to formula II and the pharmaceutically acceptable salts thereof and the method of treating cancer in a patient in need thereof by administration of said compound.
    Type: Grant
    Filed: July 25, 2007
    Date of Patent: November 16, 2010
    Assignee: Eli Lilly and Company
    Inventors: Douglas Wade Beight, Jason Scott Sawyer, Jonathan Michael Yingling
  • Pyrazolopyridine derivatives as pharmaceutical agents
    Patent number: 7365066
    Abstract: Novel pyrazolopyridine derivative compounds are disclosed and their use as pharmaceutical agents, in particular their use as TGF-beta signal transduction inhibitors useful in the treatment of cancer and other disease states influenced by TGF beta.
    Type: Grant
    Filed: September 16, 2003
    Date of Patent: April 29, 2008
    Assignee: Eli Lilly and Company
    Inventors: Douglas Wade Beight, Rosanne Bonjouklian, Junkai Liao, William Thomas McMillen, Brandon Lee Parkhurst, Jason Scott Sawyer, Jonathan Michael Yingling, Jeremy Schulenburg York
  • Quinolinyl-pyrrolopyrazoles
    Patent number: 7265225
    Abstract: A compound according to formula II and the pharmaceutically acceptable salts thereof and the method of treating cancer in a patient in need thereof by administration of said compound.
    Type: Grant
    Filed: November 10, 2003
    Date of Patent: September 4, 2007
    Assignee: Eli Lilly and Company
    Inventors: Douglas Wade Beight, Jason Scott Sawyer, Jonathan Michael Yingling
  • Pyrrole derivatives as pharmaceutical agents
    Patent number: 7087626
    Abstract: Novel pyrrazole derivative compounds and their use as pharmaceutical agents, in particular their use as TGF-beta signal transduction inhibitors.
    Type: Grant
    Filed: May 13, 2002
    Date of Patent: August 8, 2006
    Assignee: Eli Lilly and Company
    Inventors: Douglas Wade Beight, Todd Vincent DeCollo, Alexander Glenn Godfrey, Theodore Goodson, Jr., Hong-Yu Li, William Thomas McMillen, Shawn Christopher Miller, Jason Scott Sawyer, Edward C. R. Smith, Jonathan Michael Yingling
  • Novel pyrrole derivatives as pharmaceutical agents
    Publication number: 20040106604
    Abstract: Novel pyrrazole derivative compounds and their use as pharmaceutical agents, in particular their use as TGF-beta signal transduction inhibitors. The disclosed invention relates to compounds of the structure (I) wherein (I) is a four, five, or six membered saturated ring and X is C, O or S.
    Type: Application
    Filed: November 6, 2003
    Publication date: June 3, 2004
    Inventors: Douglas Beight, Todd DeCollo, Alexander Glenn Godfrey, Theodore Goodson, Hong-Yu Li, William McMillen, Shawn Christopher Miller, Jason Sawyer, Edward C.R. Smith, Jonathan Michael Yingling